In a study published today in Blood Advances, researchers found that privately insured individuals with sickle cell disease (SCD) spend approximately $1.7 million on disease-related medical expenses over their lifetime. These ...
May 16, 2022
0
20
According to a study published today in Blood Advances, people suffering from long COVID may face an increased risk of abnormal blood clotting. Investigators also found that this blood abnormality was four times more likely ...
May 11, 2022
0
110
People with sickle cell disease (SCD) who were recently prescribed a corticosteroid—a medicine frequently used to treat asthma or inflammation—were found to be significantly more likely to be hospitalized for a severe ...
Apr 26, 2022
0
54
New research published today in Blood Advances indicates that many adolescent and young adult (AYA) men with sickle cell disease (SCD) are unaware of potential SCD-associated fertility issues, highlighting a need for comprehensive ...
Apr 20, 2022
0
17
A new Blood Advances study suggests that people with cancer and non-O blood types, such as types A, B, and AB, face an increased risk of developing venous thromboembolism (VTE), or blood clots in the veins, three months ...
Apr 13, 2022
0
9
Heart abnormalities are common complications of sickle cell anemia (SCA) that can contribute to severe disease symptoms and even death. A study published today in the journal Blood Advances is the first to find that hydroxyurea ...
Sep 16, 2021
0
9
Requirements instituted to address racial and ethnic disparities in clinical trial enrollment did not lead to increased inclusion of Black and Hispanic participants in clinical acute leukemia research, according to a new ...
Sep 2, 2021
0
2
Half of pregnant women who had a simple blood test to check their iron stores had low iron levels, and one in four had severe iron deficiency, according to a paper published today in the journal Blood Advances. But despite ...
Aug 30, 2021
0
4
New research published today in the journal Blood Advances finds that certain factors, such as a history of severe pain episodes and coexisting organ conditions, increase the risk of severe COVID-19 illness, including hospitalization, ...
Jul 1, 2021
0
3
Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer. According to researchers, ...
Apr 16, 2021
0
8
